Nadine D. Tosk's Blog (1)

NEWARK, Calif.--April 2, 2018 via Business Wire

Revance Therapeutics, Inc. (NASDAQ:RVNC), a biotechnology company developing neuromodulators for use in treating aesthetic and underserved therapeutic conditions, today announced the appointments of Dustin Sjuts as Vice President of Strategy and Sales, Aesthetic and Therapeutic; Ben Putman as Vice President of Digital; and Marc Korenberg as Senior Director of Commercial Operations. In addition,…